|
|
|
Insider
Information: |
Treu Jesse I |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
24 |
|
Direct
Shares |
55,258 |
|
Indirect Shares
|
2,983,502 |
|
|
Direct
Value |
$37,649 |
|
|
Indirect Value
|
$10,776,798 |
|
|
Total
Shares |
3,038,760 |
|
|
Total
Value |
$10,814,447 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nuvasive Inc |
NUVA |
10% Owner |
|
0 |
2004-05-18 |
31,204 |
Premium* |
|
Senomyx Inc |
SNMX |
10% Owner |
|
0 |
2004-06-25 |
19,603 |
Premium* |
|
Santarus Inc |
SNTS |
10% Owner |
2004-04-06 |
0 |
2004-04-06 |
64,471 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director |
2010-06-09 |
0 |
2009-12-18 |
0 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-04-18 |
0 |
2006-12-12 |
21,068 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
Director |
2007-05-18 |
17,231 |
2007-05-18 |
14,690 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2009-01-30 |
67,875 |
Premium* |
|
Volcano Corp |
VOLC |
10% Owner |
2008-04-24 |
21,289 |
2008-07-16 |
62,513 |
Premium* |
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
|
0 |
2014-03-19 |
0 |
Premium* |
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
15,096 |
2011-12-22 |
50,643 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2010-04-27 |
0 |
2011-06-02 |
40,790 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2013-01-18 |
244,057 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2011-11-21 |
51,013 |
Premium* |
|
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
|
0 |
2012-07-24 |
22,306 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
|
0 |
2013-07-01 |
35,253 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2013-07-15 |
0 |
2013-07-15 |
1,920,730 |
Premium* |
|
Tobira Therapeutics Inc |
TBRA |
Director, 10% Owner |
|
0 |
2013-08-27 |
32,091 |
Premium* |
|
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-30 |
24,256 |
Premium* |
|
Veracyte, Inc. |
VCYT |
Director |
2019-03-04 |
1,642 |
2019-03-04 |
1,641 |
Premium* |
|
Tandem Diabetes Care Inc |
TNDM |
Director, 10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2014-02-04 |
13,004 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
Aldeyra Therapeutics, Inc. |
ALDX |
Director |
2019-03-26 |
0 |
2019-03-26 |
8,763 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
157 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NSTR |
Northstar Neuroscience In... |
Director |
|
2006-11-06 |
4 |
S |
$13.10 |
$164,143 |
I/I |
(12,530) |
25,056 |
0 |
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2006-12-06 |
4/A |
S |
$16.75 |
$25,263,154 |
I/I |
(1,508,248) |
112,200 |
0 |
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2006-12-06 |
4 |
S |
$16.75 |
$25,263,171 |
I/I |
(1,508,249) |
112,200 |
0 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2006-12-12 |
4 |
S |
$25.62 |
$330,498 |
I/I |
(12,900) |
21,068 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2006-12-21 |
4 |
S |
$13.52 |
$87,326 |
I/I |
(6,459) |
19,379 |
0 |
- |
|
NSTR |
Northstar Neuroscience In... |
Director |
|
2007-03-05 |
4 |
S |
$10.92 |
$99,208 |
I/I |
(9,085) |
15,971 |
0 |
- |
|
NSTR |
Northstar Neuroscience In... |
Director |
|
2007-05-04 |
4 |
S |
$13.00 |
$207,623 |
I/I |
(15,971) |
0 |
0 |
- |
|
NSTR |
Northstar Neuroscience In... |
Director |
|
2007-05-15 |
4 |
S |
$13.20 |
$5,002,800 |
I/I |
(379,000) |
0 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2007-05-17 |
4 |
S |
$14.50 |
$62,307 |
I/I |
(4,297) |
15,082 |
0 |
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2007-05-18 |
4 |
S |
$19.25 |
$486,005 |
I/I |
(25,247) |
91,781 |
0 |
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2007-06-01 |
4 |
S |
$20.59 |
$600,940 |
D/D |
(29,186) |
0 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2007-06-05 |
4 |
S |
$14.07 |
$49,245 |
I/I |
(3,500) |
11,582 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
|
2007-06-06 |
4 |
S |
$11.26 |
$275,870 |
I/I |
(24,500) |
73,575 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2007-11-27 |
4 |
S |
$14.27 |
$299,670 |
I/I |
(21,000) |
83,975 |
0 |
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2008-04-08 |
4 |
S |
$12.98 |
$218,479 |
I/I |
(16,832) |
78,168 |
0 |
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2008-07-16 |
4 |
S |
$14.49 |
$280,483 |
I/I |
(19,357) |
62,513 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
|
2009-01-28 |
4 |
S |
$0.93 |
$34,131 |
I/I |
(36,700) |
72,738 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
|
2009-01-29 |
4 |
S |
$0.91 |
$57,330 |
I/I |
(63,000) |
71,302 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
|
2009-01-30 |
4 |
S |
$0.98 |
$147,294 |
I/I |
(150,300) |
67,875 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-12-10 |
4 |
S |
$1.15 |
$66,125 |
I/I |
(57,500) |
14,131 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-12-11 |
4 |
S |
$1.15 |
$469,200 |
I/I |
(408,000) |
9,806 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-12-14 |
4 |
S |
$1.15 |
$40,250 |
I/I |
(35,000) |
9,435 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-12-17 |
4 |
S |
$1.04 |
$848,944 |
I/I |
(816,292) |
0 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-12-18 |
4 |
S |
$1.10 |
$88,521 |
I/I |
(80,474) |
0 |
0 |
- |
|
ALIM |
Alimera Sciences Inc |
10% Owner |
|
2011-06-02 |
4 |
S |
$8.04 |
$55,589 |
I/I |
(6,914) |
40,790 |
0 |
- |
|
157 Records found
|
|
Page 6 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|